SURITAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Surital, and what generic alternatives are available?
Surital is a drug marketed by Parkedale and is included in one NDA.
The generic ingredient in SURITAL is thiamylal sodium. There are three drug master file entries for this compound. Additional details are available on the thiamylal sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SURITAL?
- What are the global sales for SURITAL?
- What is Average Wholesale Price for SURITAL?
Summary for SURITAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 17 |
| Patent Applications: | 952 |
| DailyMed Link: | SURITAL at DailyMed |
US Patents and Regulatory Information for SURITAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parkedale | SURITAL | thiamylal sodium | INJECTABLE;INJECTION | 007600-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Parkedale | SURITAL | thiamylal sodium | INJECTABLE;INJECTION | 007600-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Parkedale | SURITAL | thiamylal sodium | INJECTABLE;INJECTION | 007600-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
